Clemedi Company
Clemedi is a company that creates diagnostic tests for infectious diseases using Next-generation Sequencing and Machine learning technologies. Their goal is to help reduce the number of deaths caused by antibiotic resistant bacteria, which is expected to reach 10 million annually by 2050. Their tests assist doctors in making timely and personalized decisions regarding antibiotic therapy, ultimately benefiting patients with infectious diseases.
Connections
Total Funding:
30000.0
Headquarters:
Schlieren, Zurich, Switzerland
Last Funding Type:
Non-equity Assistance
Last Funding Date:
2019-05-15
Investors Number:
2.0
Founded Date:
2018-01-01
Industry:
Data Processing